What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Disease
His scientific interests lie mostly in Autoantibody, Immunology, Bullous pemphigoid, Pemphigus and Dermatology.
His Autoantibody study focuses on Epidermolysis bullosa acquisita in particular.
In his research, Cell adhesion and Cell biology is intimately related to Keratinocyte, which falls under the overarching field of Immunology.
When carried out as part of a general Bullous pemphigoid research project, his work on Pemphigoid is frequently linked to work in Doxycycline, therefore connecting diverse disciplines of study.
Enno Schmidt has included themes like Pemphigus vulgaris, Desmoglein, Rheumatoid arthritis and Rituximab in his Pemphigus study.
The Dermatology study combines topics in areas such as Differential diagnosis, Adjuvant, Severity of illness, Pemphigoid Gestationis and Immunoadsorption.
His most cited work include:
- Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid. (260 citations)
- The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement. (185 citations)
- Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts (178 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Immunology, Autoantibody, Bullous pemphigoid, Dermatology and Pemphigoid.
His work carried out in the field of Autoantibody brings together such families of science as Pemphigus, Direct fluorescent antibody and Disease, Pathology.
He combines subjects such as Desmoglein, Rituximab and Pemphigus vulgaris with his study of Pemphigus.
His work is dedicated to discovering how Bullous pemphigoid, Internal medicine are connected with Gastroenterology and other disciplines.
His studies deal with areas such as Adjuvant, Immunoadsorption and MEDLINE as well as Dermatology.
His Pemphigoid research is multidisciplinary, incorporating elements of Serology and Recombinant DNA.
He most often published in these fields:
- Immunology (41.62%)
- Autoantibody (42.16%)
- Bullous pemphigoid (40.54%)
What were the highlights of his more recent work (between 2018-2021)?
- Bullous pemphigoid (40.54%)
- Autoantibody (42.16%)
- Pemphigoid (29.19%)
In recent papers he was focusing on the following fields of study:
Enno Schmidt spends much of his time researching Bullous pemphigoid, Autoantibody, Pemphigoid, Dermatology and Pemphigus.
Immunology and Antibody are the two main areas of interest in his Bullous pemphigoid studies.
His work in Autoantibody covers topics such as Direct fluorescent antibody which are related to areas like Biopsy.
The study incorporates disciplines such as Cell biology, Epidermolysis bullosa acquisita, Serology and Pathology in addition to Pemphigoid.
His work deals with themes such as Guideline and MEDLINE, which intersect with Dermatology.
Enno Schmidt has included themes like Desmoglein, Rituximab and Pemphigus vulgaris in his Pemphigus study.
Between 2018 and 2021, his most popular works were:
- Expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemic. (32 citations)
- IL-17A is functionally relevant and a potential therapeutic target in bullous pemphigoid. (30 citations)
- SARS-CoV-2 Transmission from Presymptomatic Meeting Attendee, Germany. (26 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Disease
Enno Schmidt mostly deals with Pemphigoid, Bullous pemphigoid, Dermatology, Pemphigus and Autoantibody.
His Pemphigoid research includes elements of Inflammation, Autoimmunity, Immune system and Pathology.
His Bullous pemphigoid study deals with the bigger picture of Immunology.
His work investigates the relationship between Dermatology and topics such as MEDLINE that intersect with problems in Virology and Desmosome.
Enno Schmidt has researched Pemphigus in several fields, including Pemphigus vulgaris, Guideline, Therapeutic trial, Desmoglein and Gynecology.
His Autoantibody study incorporates themes from Internal medicine, Skin pathology, Antigen and Complement fixation test.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
